SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently trending as investors focus on its strategic positioning in defense and space applications, alongside its participation in high-level White House quantum technology events. The community is actively debating the stock's valuation relative to its peers and government support, with many discussing the potential impact of looming regulatory deadlines on the company's future contracts.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is driving significant market conversation following the release of Muse Spark 1.1 and reports of an aggressive expansion in AI compute infrastructure, including plans to manufacture custom AI chips. While some community members remain skeptical of high capital expenditure, the stock is seeing strong institutional interest and a bullish technical reversal, with active discussions focusing on the company's competitive positioning against other frontier AI labs.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is trending as investors react to reports of impending foundry price hikes and continued robust demand for advanced manufacturing capacity. The community is closely watching upcoming monthly sales data and company updates as critical indicators of whether the firm can sustain its leadership amid ongoing semiconductor supply bottlenecks.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently the focus of intense investor attention, driven by anticipation of upcoming preliminary revenue announcements and potential catalysts related to international expansion and further FDA trial progress. While the community is actively debating the impact of ongoing short interest and regulatory headwinds, sentiment remains buoyed by high-conviction retail holders who view recent price volatility as a potential accumulation opportunity ahead of anticipated news.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as market participants debate its long-term viability amid ongoing price volatility and comparisons to other memecoins. Community members remain polarized, with vocal supporters looking for accumulation opportunities and potential recovery catalysts, while skeptics warn of downward trends and diminishing utility.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is drawing investor attention as it prepares to present new clinical data on its ITK inhibitor, soquelitinib, at upcoming medical conferences. While some community members highlight the potential of its immune-modulating pipeline and recent insider buying as bullish catalysts, others remain skeptical about the company's long-term commercialization strategy and the competitive pressures from major pharmaceutical players in the immunology space.

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Arbutus Biopharma is seeing significant investor attention following the FDA's grant of Fast Track designation for its chronic hepatitis B candidate, imdusiran, alongside ongoing monitoring of institutional accumulation and pending patent litigation outcomes. The community is actively discussing the company's valuation, potential strategic partnerships or buyout scenarios, and frustration regarding the lack of proactive communication from leadership following the recent Moderna settlement.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

UniSwap is generating significant community buzz following the 'UNIfication' governance proposal, which aims to activate a fee switch and implement a massive token burn to drive long-term deflationary pressure. Investors are actively debating the token's potential to re-establish bullish momentum while closely monitoring institutional developments and technical indicators for signs of a sustained breakout.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is seeing heightened investor attention as the company aggressively expands its Hydrochemolytic technology into the paraffinic crude oil sector, highlighted by new strategic hires and industry association memberships. The community remains deeply divided, with bulls pointing to institutional interest and potential asymmetric upside, while skeptics demand more transparency regarding the commercial unit economics of their various recycling verticals.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is experiencing significant downward pressure as investors rotate capital into high-growth AI and semiconductor stocks, despite bullish institutional signals and recent insider accumulation. The community is actively debating whether the current sell-off represents a structural collapse or a rare value-buying opportunity in an oversold, high-quality medical device leader.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRSR ➡️➡️➡️➡️➡️ SRXH  
--------------- SRXH --------------- 
 
BUY ---&gt;&gt;&gt;&gt;&gt; SRXH

Jason long

StockTwits Web

Corsair Gaming Inc

 ➡️➡️➡️➡️➡️ SRXH  
--------------- SRXH --------------- 
 
BUY --->>>>> SRXH